What is Renovorx Inc's earnings per share (EPS)?

Renovorx Inc (RNXT) reported diluted earnings per share of $-0.32 for fiscal year 2025. This represents a 20.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Renovorx Inc Financials

RNXT

Source SEC Filings (10-K/10-Q) Updated Mar 30, 2026 Currency USD FYE March

This page shows Renovorx Inc (RNXT) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 45/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Renovorx Inc has an operating margin of -1114.0%, meaning the company retains $-1114 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -25511.6% the prior year.

Growth

100

Renovorx Inc's revenue surged 2511.6% year-over-year to $1.1M, reflecting rapid business expansion. This strong growth earns a score of 100/100.

Leverage

Renovorx Inc carries a low D/E ratio of 0.49, meaning only $0.49 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 92/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

With a current ratio of 4.02, Renovorx Inc holds $4.02 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 79/100.

Cash Flow

While Renovorx Inc generated -$11.0M in operating cash flow, capex of $2K consumed most of it, leaving -$11.0M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.

Returns

Renovorx Inc generates a -206.0% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is down from -196.8% the prior year.

Piotroski F-Score Weak

2/9

Renovorx Inc passes 2 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality Low Quality

0.98x

For every $1 of reported earnings, Renovorx Inc generates $0.98 in operating cash flow (-$11.0M OCF vs -$11.2M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$1.1M

YoY+2511.6%

Renovorx Inc generated $1.1M in revenue in fiscal year 2025. This represents an increase of 2511.6% from the prior year.

EBITDA

-$10.5M

Renovorx Inc's EBITDA was -$10.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Net Income

-$11.2M

YoY-26.7%

Renovorx Inc reported -$11.2M in net income in fiscal year 2025. This represents a decrease of 26.7% from the prior year.

EPS (Diluted)

$-0.32

YoY+20.0%

Renovorx Inc earned $-0.32 per diluted share (EPS) in fiscal year 2025. This represents an increase of 20.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow

-$11.0M

YoY-20.1%

Renovorx Inc generated -$11.0M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 20.1% from the prior year.

Cash & Debt

$7.0M

YoY-1.8%

5Y CAGR+31.4%

Renovorx Inc held $7.0M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

45M

YoY+87.4%

Renovorx Inc had 45M shares outstanding in fiscal year 2025. This represents an increase of 87.4% from the prior year.

Margins & Returns

Gross Margin

70.9%

YoY-29.1pp

Renovorx Inc's gross margin was 70.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 29.1 percentage points from the prior year.

Operating Margin

-1114.0%

YoY+24397.6pp

Renovorx Inc's operating margin was -1114.0% in fiscal year 2025, reflecting core business profitability. This is up 24397.6 percentage points from the prior year.

Net Margin

-994.5%

YoY+19503.2pp

Renovorx Inc's net profit margin was -994.5% in fiscal year 2025, showing the share of revenue converted to profit. This is up 19503.2 percentage points from the prior year.

Return on Equity

-206.0%

YoY-9.2pp

Renovorx Inc's ROE was -206.0% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 9.2 percentage points from the prior year.

Capital Allocation

R&D Spending

$6.3M

YoY+4.0%

5Y CAGR+21.3%

Renovorx Inc invested $6.3M in research and development in fiscal year 2025. This represents an increase of 4.0% from the prior year.

Share Buybacks

N/A

Capital Expenditures

$2K

YoY-83.3%

Renovorx Inc invested $2K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 83.3% from the prior year.

RNXT Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$1.1M+2511.6%	$43K	N/A	N/A	N/A	N/A
Cost of Revenue	$327K	N/A	N/A	N/A	N/A	N/A
Gross Profit	$796K+1751.2%	$43K	N/A	N/A	N/A	N/A
R&D Expenses	$6.3M+4.0%	$6.0M+6.3%	$5.7M+31.8%	$4.3M+41.5%	$3.0M+27.4%	$2.4M
SG&A Expenses	$7.0M+41.1%	$5.0M-12.9%	$5.7M+1.4%	$5.6M+114.6%	$2.6M+221.8%	$818K
Operating Income	-$12.5M-14.0%	-$11.0M+3.7%	-$11.4M-14.5%	-$9.9M-75.5%	-$5.7M-77.0%	-$3.2M
Interest Expense	N/A	N/A	N/A	N/A	-$834K-42.1%	-$587K
Income Tax	$2K	N/A	N/A	N/A	N/A	N/A
Net Income	-$11.2M-26.7%	-$8.8M+13.9%	-$10.2M-3.5%	-$9.9M-56.4%	-$6.3M-66.5%	-$3.8M
EPS (Diluted)	$-0.32+20.0%	$-0.40+59.6%	$-0.99+9.2%	$-1.09	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Revenue	$266K-37.0%	$422K+114.2%	$197K	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	$53K-65.1%	$152K+61.7%	$94K	N/A	N/A	N/A	N/A	N/A
Gross Profit	$213K-21.1%	$270K+162.1%	$103K	N/A	N/A	N/A	N/A	N/A
R&D Expenses	$1.7M+18.2%	$1.4M-13.2%	$1.6M	N/A	$1.6M+7.0%	$1.5M+22.7%	$1.3M	N/A
SG&A Expenses	$1.7M+13.5%	$1.5M-3.1%	$1.6M	N/A	$1.2M-21.0%	$1.5M+22.4%	$1.2M	N/A
Operating Income	-$3.2M-19.5%	-$2.7M+13.9%	-$3.1M	N/A	-$2.8M+6.8%	-$3.0M-22.5%	-$2.5M	N/A
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	N/A	N/A	$0	N/A	N/A	N/A	$0	N/A
Net Income	-$2.9M-0.6%	-$2.9M-19.6%	-$2.4M	N/A	-$2.5M-3.4%	-$2.4M-122.0%	-$1.1M	N/A
EPS (Diluted)	$-0.080.0%	$-0.080.0%	$-0.08	N/A	$-0.100.0%	$-0.10-42.9%	$-0.07	N/A

RNXT Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$8.1M-0.3%	$8.1M+453.8%	$1.5M-79.8%	$7.3M-55.4%	$16.3M+750.9%	$1.9M
Current Assets	$7.9M+0.8%	$7.8M+434.0%	$1.5M-79.8%	$7.3M-55.4%	$16.3M+752.4%	$1.9M
Cash & Equivalents	$7.0M-1.8%	$7.2M+509.9%	$1.2M-73.3%	$4.4M-71.1%	$15.2M+746.4%	$1.8M
Inventory	$189K	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$139K+223.3%	$43K	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$2.7M-26.6%	$3.6M-18.5%	$4.5M+305.3%	$1.1M+17.5%	$938K-94.3%	$16.6M
Current Liabilities	$2.0M+2.8%	$1.9M+62.5%	$1.2M+6.6%	$1.1M+17.5%	$938K-77.1%	$4.1M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$5.4M+21.1%	$4.5M+249.3%	-$3.0M-148.7%	$6.2M-59.8%	$15.3M+204.7%	-$14.7M
Retained Earnings	-$61.4M-22.2%	-$50.2M-21.3%	-$41.4M-32.8%	-$31.2M-46.5%	-$21.3M-42.3%	-$15.0M

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Total Assets	$11.2M-17.9%	$13.6M-14.8%	$16.0M+97.3%	$8.1M-19.1%	$10.0M-16.4%	$12.0M+150.7%	$4.8M+226.6%	$1.5M
Current Assets	$11.0M-18.0%	$13.4M-14.9%	$15.7M+101.1%	$7.8M	N/A	N/A	N/A	$1.5M
Cash & Equivalents	$10.0M-18.4%	$12.3M-15.6%	$14.6M+103.8%	$7.2M-25.2%	$9.6M-18.6%	$11.7M+167.5%	$4.4M+274.2%	$1.2M
Inventory	$272K	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$169K-53.4%	$363K+50.0%	$242K+462.8%	$43K	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$3.1M+4.2%	$3.0M+5.1%	$2.9M-21.5%	$3.6M+23.0%	$3.0M+8.3%	$2.7M-9.6%	$3.0M-32.4%	$4.5M
Current Liabilities	$1.9M+21.1%	$1.6M-10.4%	$1.7M-9.1%	$1.9M+7.7%	$1.8M+35.2%	$1.3M+19.9%	$1.1M-7.0%	$1.2M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$8.1M-24.1%	$10.6M-19.1%	$13.2M+193.8%	$4.5M-36.7%	$7.1M-23.7%	$9.3M+424.7%	$1.8M+158.9%	-$3.0M
Retained Earnings	-$58.4M-5.2%	-$55.5M-5.5%	-$52.6M-4.8%	-$50.2M-6.1%	-$47.3M-5.5%	-$44.9M-5.6%	-$42.5M-2.6%	-$41.4M

RNXT Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	-$11.0M-20.3%	-$9.1M+11.0%	-$10.3M-16.4%	-$8.8M-48.9%	-$5.9M-67.7%	-$3.5M
Capital Expenditures	$2K-83.3%	$12K	N/A	N/A	N/A	N/A
Free Cash Flow	-$11.0M-20.1%	-$9.1M	N/A	N/A	N/A	N/A
Investing Cash Flow	-$2K+83.3%	-$12K-100.6%	$2.0M+200.0%	-$2.0M-13446.7%	-$15K	N/A
Financing Cash Flow	$10.8M-28.3%	$15.1M+201.9%	$5.0M+11823.8%	$42K-99.8%	$19.3M+504.2%	$3.2M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Operating Cash Flow	-$2.3M+1.4%	-$2.3M+31.9%	-$3.4M-39.1%	-$2.4M-10.8%	-$2.2M+4.5%	-$2.3M-4.2%	-$2.2M-7.4%	-$2.1M
Capital Expenditures	$0	$0-100.0%	$2K	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	-$2.3M+1.4%	-$2.3M+32.0%	-$3.4M	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	$0	$0+100.0%	-$2K	N/A	N/A	N/A	N/A	$0
Financing Cash Flow	$0-100.0%	$34K-99.7%	$10.8M+32660.6%	$33K+120.0%	$15K-99.8%	$9.7M+78.0%	$5.4M	$0
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

RNXT Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	70.9%-29.1pp	100.0%	N/A	N/A	N/A	N/A
Operating Margin	-1114.0%+24397.6pp	-25511.6%	N/A	N/A	N/A	N/A
Net Margin	-994.5%+19503.2pp	-20497.7%	N/A	N/A	N/A	N/A
Return on Equity	-206.0%-9.2pp	-196.8%	N/A	-160.5%-119.3pp	-41.2%	N/A
Return on Assets	-138.0%-29.4pp	-108.6%+589.4pp	-697.9%-561.8pp	-136.1%-97.3pp	-38.8%+159.6pp	-198.4%
Current Ratio	4.02-0.1	4.10+2.9	1.25-5.3	6.59-10.8	17.36+16.9	0.47
Debt-to-Equity	0.49-0.3	0.81+2.3	-1.49-1.7	0.18+0.1	0.06+1.2	-1.13
FCF Margin	-977.3%+20271.6pp	-21248.8%	N/A	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Gross Margin	80.1%+16.1pp	64.0%+11.7pp	52.3%	N/A	N/A	N/A	N/A	N/A
Operating Margin	-1203.0%-568.4pp	-634.6%+944.1pp	-1578.7%	N/A	N/A	N/A	N/A	N/A
Net Margin	-1094.7%-408.7pp	-686.0%+542.4pp	-1228.4%	N/A	N/A	N/A	N/A	N/A
Return on Equity	-36.0%-8.8pp	-27.2%-8.8pp	-18.4%	N/A	-34.9%-9.2pp	-25.8%+35.1pp	-60.9%	N/A
Return on Assets	-26.0%-4.8pp	-21.2%-6.1pp	-15.1%	N/A	-24.6%-4.7pp	-19.9%+2.6pp	-22.5%	N/A
Current Ratio	5.83-2.8	8.61-0.5	9.07+5.0	4.10	N/A	N/A	N/A	1.25
Debt-to-Equity	0.39+0.1	0.28+0.1	0.22-0.6	0.81+0.4	0.42+0.1	0.29-1.4	1.71+3.2	-1.49
FCF Margin	-853.4%-307.9pp	-545.5%+1171.8pp	-1717.3%	N/A	N/A	N/A	N/A	N/A

Similar Companies

Plus Therapeutics Inc PSTV

$24.4M

Bioatla, Inc. BCAB

$216K

Tempest Therapeutics Inc TPST

$22.8M

Telomir Pharms TELO

$43.7M

Renovaro RENB

$32.9M

Frequently Asked Questions

What is Renovorx Inc's annual revenue?

Renovorx Inc (RNXT) reported $1.1M in total revenue for fiscal year 2025. This represents a 2511.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Renovorx Inc's revenue growing?

Renovorx Inc (RNXT) revenue grew by 2511.6% year-over-year, from $43K to $1.1M in fiscal year 2025.

Is Renovorx Inc profitable?

No, Renovorx Inc (RNXT) reported a net income of -$11.2M in fiscal year 2025, with a net profit margin of -994.5%.

What is Renovorx Inc's EBITDA?

Renovorx Inc (RNXT) had EBITDA of -$10.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Renovorx Inc's gross margin?

Renovorx Inc (RNXT) had a gross margin of 70.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Renovorx Inc's operating margin?

Renovorx Inc (RNXT) had an operating margin of -1114.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Renovorx Inc's net profit margin?

Renovorx Inc (RNXT) had a net profit margin of -994.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Renovorx Inc's return on equity (ROE)?

Renovorx Inc (RNXT) has a return on equity of -206.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Renovorx Inc's free cash flow?

Renovorx Inc (RNXT) generated -$11.0M in free cash flow during fiscal year 2025. This represents a -20.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Renovorx Inc's operating cash flow?

Renovorx Inc (RNXT) generated -$11.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Renovorx Inc's total assets?

Renovorx Inc (RNXT) had $8.1M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Renovorx Inc's capital expenditures?

Renovorx Inc (RNXT) invested $2K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Renovorx Inc spend on research and development?

Renovorx Inc (RNXT) invested $6.3M in research and development during fiscal year 2025.

How many shares does Renovorx Inc have outstanding?

Renovorx Inc (RNXT) had 45M shares outstanding as of fiscal year 2025.

What is Renovorx Inc's current ratio?

Renovorx Inc (RNXT) had a current ratio of 4.02 as of fiscal year 2025, which is generally considered healthy.

What is Renovorx Inc's debt-to-equity ratio?

Renovorx Inc (RNXT) had a debt-to-equity ratio of 0.49 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Renovorx Inc's return on assets (ROA)?

Renovorx Inc (RNXT) had a return on assets of -138.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Renovorx Inc's cash runway?

Based on fiscal year 2025 data, Renovorx Inc (RNXT) had $7.0M in cash against an annual operating cash burn of $11.0M. This gives an estimated cash runway of approximately 8 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

What is Renovorx Inc's Piotroski F-Score?

Renovorx Inc (RNXT) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Renovorx Inc's earnings high quality?

Renovorx Inc (RNXT) has an earnings quality ratio of 0.98x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Renovorx Inc?

Renovorx Inc (RNXT) scores 45 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.